Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to start review
Explore by Goal
"The universe is not only queerer than we suppose, but queerer than we can suppose."
- J.B.S. Haldane
Quick Explanation
Copied
Weiss system (25 years later) — what holds up, what’s tricky, what to doubt
The paper reiterates that the Weiss histologic score (9 criteria, equal weight; malignancy when ≥3) was derived from a follow-up–anchored cohort and has remained the practical histopathologic backbone for adult adrenocortical malignancy risk stratification .
It also emphasizes key ‘blind spots’: pediatric tumors and oncocytic tumors can violate adult assumptions—i.e., adult Weiss criteria may not map cleanly to outcome in those contexts .
Scientifically skeptical take: the system is strongly outcome-linked in the original/validation settings described, but because it is morphology-based and uses cutoffs, misclassification risk likely concentrates around interpretive criteria and on contexts with different biology .
Long Explanation
Paper Review (visual-first): Weiss system for adrenocortical neoplasms
Target paper: 10.1016/j.humpath.2009.03.010 — “The Weiss system for evaluating adrenocortical neoplasms: 25 years later” .
Adult Weiss score is presented as a practical morphology→outcome proxy: the review describes derivation and cutoff shifts, plus reported outcome correlations across studies .
Not all biology behaves like “adult typical”: pediatric and oncocytic settings are treated as distinct enough that adult Weiss criteria may be non-transferable .
Interpretation subjectivity is a known failure mode: the review connects reproducibility issues for certain criteria to development of the modified Weiss system .
1) Weiss scoring logic (adult) — what is actually being counted
The review describes the original Weiss system as 9 histologic criteria (each scored 1 if present, 0 if absent; total 0–9) and states the malignancy decision breakpoint was later lowered from ≥4 to ≥3 criteria based on additional experience .
Weiss criteria enumerated by the review
High nuclear grade (mapped to Fuhrman grade 3–4) .
Mitotic rate > 5 per 50 high-power fields .
Atypical mitoses (abnormal chromosomal distribution or multipolar mitotic spindles) .
Capsule invasion (extension into or traversing capsule with associated stromal reaction) .
2) Decision breakpoint evidence (from the review’s reported outcome numbers)
The review reports early outcome separation at the original cutoff (≥4 vs ≤2) and later recalibration to ≥3, including reported recurrence/metastasis percentages .
The review’s narrative additionally states that using 3 instead of 4 as a breakpoint preserved efficacy and reports 91% recurrence/metastasis in patients with ≥3 criteria .
Skeptical check
These percentages are outcome-linked summaries as presented by the review; the review text does not provide full denominators for every quoted percentage in the snippets shown here, so misreading risk exists if one over-generalizes beyond the specific cohorts/study designs .
3) Modified Weiss system — reproducibility-driven simplification
The review explains that some original Weiss criteria can be difficult and subject to interobserver variability; therefore, a modified version was proposed that uses a smaller set of criteria selected for higher interobserver agreement (κ). It scores 5 criteria with an overall range 0–7 and considers malignancy when the score is ≥3 .
4) Contexts where the paper argues Weiss-from-adults may fail
4.1 Pediatric adrenocortical neoplasms
The review states that evidence indicates adult-developed systems (including Weiss) are not entirely applicable to pediatric tumors and may not accurately predict outcome; multiple adult “worrisome” features can still correspond to clinically benign behavior in children .
Counts are only those explicitly stated in the provided paper text excerpt (poor outcome defined as recurrence/metastasis and/or death from disease). .
4.2 Oncocytic adrenocortical neoplasms
The review argues oncocytic tumors are special because many Weiss criteria that are prognostically informative in non-oncocytic tumors become common (e.g., eosinophilic oncocytic cytology, diffuse architecture, high nuclear atypia), reducing their discriminative power; it therefore describes guidelines with “major” vs “minor” criteria plus an intermediate borderline category .
The review summarizes that molecular genetic techniques have identified differences between benign and malignant adrenocortical tumors, including reported copy-number patterns and recurrent allelic losses at specific loci; it also describes transcriptional profiling signatures and discusses that diagnostic clinical use remains to be standardized/validated .
A minimal evidence graph: “Weiss remains mainstay” vs “molecular promising”
This plot is a narrative-emphasis visualization based only on what the review states (e.g., that Weiss remains mainstay; molecular classification is promising but needs further standardization/validation). It is not a quantitative meta-analytic effect size .
Strength: The review’s core thesis is tightly coupled to follow-up–anchored outcome associations and to reproducibility engineering (modified Weiss based on κ-driven criterion selection) .
Key blind spot (inherent to morphology scores): many criteria require interpretation (e.g., mitotic atypia, “diffuse” proportion, distinguishing invasion vs artifact), so errors can propagate from sectioning, staining, and observer judgment .
Population heterogeneity: the review explicitly argues for non-transferability to pediatric and oncocytic contexts, which is a major counterpoint against blanket generalization .
Biomarker transition risk: even though IHC/molecular tools are described as promising, the review highlights lack of a standard Ki-67 threshold and calls for further standardization/validation before clinical use .
Author review links (bespoke follow-ups)
Feedback:
Updated: April 09, 2026
BGPT Paper Review
Study Novelty
70%
A 2009 review-perspective compiling and updating the Weiss system after 25 years is not conceptually novel (Weiss is older), but it does provide a structured “25-years-later” synthesis including specific modern caveats (pediatric/oncocytic) and reproducibility-driven modification discussion .
Scientific Quality
80%
As presented, the paper’s internal logic is coherent: it explains criterion definitions, scoring rules, cutoff calibration, and provides outcome-linked statements plus discusses limitations where adult-based morphology may not generalize (pediatrics/oncocytic) . Limit: the excerpted text here does not expose full study-level methodological details (sample selection, statistical intervals), so quantitative confidence cannot be fully reconstructed from the provided material .
Study Generality
60%
It is broadly useful for adrenal pathology practice in adults but explicitly narrows generality by emphasizing pediatric and oncocytic non-transferability; that improves correctness but reduces universality .
Study Usefulness
80%
High practical value for histopathology decision-making because it operationalizes criteria, explains scoring/breakpoints, and provides guidance for reproducibility and special subtypes .
Study Reproducibility
70%
Reproducibility is addressed conceptually via the modified Weiss system’s κ-selected criteria, but full reproducibility assessment (interobserver κ values by criterion, training effects, lab-to-lab calibration) is not fully reconstructable from the provided excerpt alone .
Explanatory Depth
70%
The paper explains the decision rule (counted morphology features) and discusses why certain features matter (and where they don’t), but it remains largely descriptive/perspective-based rather than mechanistic in a molecular-causal sense .
It will parse the review’s reported cutoff-outcome numbers into structured tables, then generate calibration-style plots comparing ≥2 vs ≥3 vs ≥4 criteria separations for immediate visual audit.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The hypothesis that adult Weiss thresholds (≥3) are universally predictive across pediatric tumors is unlikely given the review’s statement that adult criteria do not accurately predict pediatric outcome and that adult worrisome features can be clinically benign.
The hypothesis that Ki-67 can be used with a single universal cutoff to replace Weiss is less supported because the review states that Ki-67 labeling ranges overlap and that suggested thresholds vary without a standard accepted cutoff.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion